J&J Subsidiaries Fight Back Generic Challenge

Law360, New York (July 7, 2006, 12:00 AM EDT) -- Subsidiaries of Johnson & Johnson are suing a generic drug maker for patent infringement, hoping to block its attempts to market a generic version of a drug used to treat Alzheimer’s disease.